The FDA is relaxing the rules on the abortion pill mifepristone, saying pharmacies can now fill prescriptions for the drug so long as they become certified to do so.
Mifepristone and Misoprostol, the two drugs used in a medication abortion, are seen at the Women's Reproductive Clinic in Santa Teresa, N.M.The abortion pill mifepristone is safe enough that retail pharmacies can begin dispensing it so long as a certified health care provider prescribes the drug and if that pharmacy meets certain requirements, according toIf pharmacies jump on board, the FDA action could dramatically expand access to the drug in states where it's already legal.
Evan Masingill, CEO of GenBioPro, which manufactures the generic version of the abortion pill, called the FDA action "a step in the right direction" to increase access and one that would "minimize the burden" on the health care system. But he noted the impact would be uneven. Kirsten Moore, director of the Expanding Medication Abortion Access Project, said it's not clear how quickly Americans might see an impact or how sweeping those changes might be. Pharmacies would have to raise their hand to become certified to fill prescriptions for the drug, and even then some pharmacists might refuse to dispense the pill personally because of religious objections.
Opponents of abortion rights said a top priority this year is challenging the FDA's approval of the drug in court and trying to convince the government to crack down on unregulated sites selling the pill online. In one closely watched case in a federal court in Texas, the Alliance for Defending Freedom argued the FDA overstepped its authority in greenlighting the drug more than two decades ago.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
FDA decision on experimental Alzheimer's drug expected this week | CNNThe US Food and Drug Administration could decide this week whether to grant accelerated approval to the experimental Alzheimer's drug lecanemab, according to Eisai and Biogen, the companies that make the drug.
Consulte Mais informação »
House investigation finds FDA, drug firm Biogen ignored internal concerns for Alzheimer's drugA congressional investigation into the FDA's review process for an Alzheimer's treatment found that the agency 'deviated' from its standard procedures to approve the Aduhelm drug with inconsistent data.
Consulte Mais informação »
Sesame joins the major food allergens list, FDA saysSesame has joined the list of major food allergens defined by law, according to the U.S. Food and Drug Administration.
Consulte Mais informação »
Controversial Alzheimer's drug, explained: What to know about Aduhelm, FDA and scathing reportThe FDA's approval process of Alzheimer’s drug Aduhelm has been deemed “rife with irregularities,” according to a congressional investigation. Here are takeaways from the report.
Consulte Mais informação »
Evaxion's stock soars after getting FDA approval for mid-stage cancer trialU.S.-listed shares of Evaxion Biotech A/S undefined jumped about 17% in premarket trading on Tuesday after the company said the Food and Drug Administration...
Consulte Mais informação »
FDA Approves Wegovy (Semaglutide) for Obesity in Teens 12 and UpFDA approves semaglutide 2.4mg (Wegovy), a once-weekly subcutaneous injection, for treating obesity in adolescents aged 12 years and older.
Consulte Mais informação »